1195 related articles for article (PubMed ID: 15289356)
1. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor signaling in anti-cancer immunity.
Okamoto M; Sato M
J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent.
Oshikawa T; Okamoto M; Tano T; Sasai A; Kan S; Moriya Y; Ryoma Y; Saito M; Akira S; Sato M
J Immunother; 2006; 29(2):143-50. PubMed ID: 16531815
[TBL] [Abstract][Full Text] [Related]
4. [Anti-cancer effect of an intratumoral injection of dendritic cells expressing TLR4 in combination with an active component of OK-432 in TLR4-deficient mice].
Oshikawa T; Okamoto M; Ahmed SU; Tano T; Yoshida H; Sato M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1770-2. PubMed ID: 15553710
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
Oshikawa T; Okamoto M; Ohe G; Furuichi S; Nishikawa H; Uddin Ahmed S; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Int Immunopharmacol; 2003 May; 3(5):643-55. PubMed ID: 12757734
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide.
Nakahara S; Tsunoda T; Baba T; Asabe S; Tahara H
Cancer Res; 2003 Jul; 63(14):4112-8. PubMed ID: 12874015
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK-432.
Okamoto M; Oshikawa T; Tano T; Ohe G; Furuichi S; Nishikawa H; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
J Natl Cancer Inst; 2003 Feb; 95(4):316-26. PubMed ID: 12591988
[TBL] [Abstract][Full Text] [Related]
8. [Anti-tumor effect of intratumoral administration of dendritic cells in combination with TS-1 and OK-432].
Okamoto M; Ahmed SU; Oshikawa T; Tano T; Sato M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1627-30. PubMed ID: 15553665
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
[TBL] [Abstract][Full Text] [Related]
10. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effect of an intratumoral administration of dendritic cells in combination with TS-1, an oral fluoropyrimidine anti-cancer drug, and OK-432, a streptococcal immunopotentiator: involvement of toll-like receptor 4.
Ahmed SU; Okamoto M; Oshikawa T; Tano T; Sasai A; Kan S; Hiroshima T; Ohue H; Moriya Y; Ryoma Y; Saito M; Sato M
J Immunother; 2004; 27(6):432-41. PubMed ID: 15534487
[TBL] [Abstract][Full Text] [Related]
12. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells.
Frleta D; Noelle RJ; Wade WF
J Leukoc Biol; 2003 Dec; 74(6):1064-73. PubMed ID: 12960264
[TBL] [Abstract][Full Text] [Related]
13. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the immuno-activation mechanism of OK-432--phagocytosis, release of active components and TLR4 signaling].
Tano T; Okamoto M; Oshikawa T; Ahmed SU; Sato M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1767-9. PubMed ID: 15553709
[TBL] [Abstract][Full Text] [Related]
15. [Induction of apoptosis in human head and neck cancer cell lines by an active component of OK-432 through p53-independent pathway via toll-like receptor (TLR) 4 signaling].
Tano T; Okamoto M; Oshikawa T; Ahmed SU; Sasai A; Sato M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1562-4. PubMed ID: 16315869
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of anti-tumor immunity by lipoteichoic acid-related molecule isolated from OK-432, a streptococcal agent, in athymic nude mice bearing human salivary adenocarcinoma: role of natural killer cells.
Okamoto M; Ohe G; Furuichi S; Nishikawa H; Oshikawa T; Tano T; Ahmed SU; Yoshida H; Moriya Y; Matsubara S; Ryoma Y; Saito M; Sato M
Anticancer Res; 2002; 22(6A):3229-39. PubMed ID: 12530069
[TBL] [Abstract][Full Text] [Related]
17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
18. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
19. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.
Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL
J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
